|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
StageMark Completes $1.6 Million Venture Capital Financing
4/23/2007 12:05:19 PM
PITTSBURGH, Pa.--(BUSINESS WIRE)--StageMark, Inc., a cell analysis company developing innovative research and diagnostic products and services for autoimmune diseases, announced today that it had completed a Series B Convertible Preferred Stock financing totaling approximately $1.6 million in cash and debt conversion. The financing was led by the BioAdvance Ventures, an early stage venture fund managed by Quaker BioVentures, and the University City Science Center (UCSC). Previous investors, BlueTree Capital Partners, Innovation Works, Meyer Ventures and the Pittsburgh Life Sciences Greenhouse, also participated in the offering.
|
|
|
|
|
|
|
|
|
|
|